Bone Biologics delays annual shareholder meeting to Sept. 28 from Aug. 11
BBLG•Annual shareholder meeting postponed
Bone Biologics postponed its 2026 annual shareholder meeting to Sept. 28 from Aug. 11.
The delay allows time for investors to review proxy materials tied to an added proposal in a forthcoming definitive proxy filing.
A new record date has been set for Aug. 6, and the meeting is scheduled for 11:30 a.m. ET at the company’s Burlington, Massachusetts offices.
The deadline for shareholder director nominations or other proposals has been reset to July 26.




